Rapid normalization of severe hypercholesterolemia mediated by lipoprotein X after liver transplantation in a patient with cholestasis - a case report

Acta Biochim Pol. 2015;62(3):621-3. doi: 10.18388/abp.2015_971. Epub 2015 Aug 28.

Abstract

Hypercholesterolemia is a common disorder in adult population, but total cholesterol concentrations beyond 1000 mg/dl occur rarely, and are found in patients with homozygous familial hypercholesterolemia and familial lecithin-cholesterol acyltransferase deficiency, in chronic graft-versus-host disease of the liver, after intravenous infusion of fat emulsion (intralipid), in newborn infants with immature liver function, and in obstructive biliary cholestasis. Cholestasis induces a dramatic increase in plasma cholesterol and the appearance of an abnormal lipoprotein, lipoprotein X (LpX), in the plasma. We report a case of severe hypercholesterolemia mediated by LpX in a patient transplanted for primary biliary cirrhosis (PBC), who was qualified for liver re-transplantation (re-LTx) due to chronic cholestasis. Four months after re-LTx, the cholesterol concentration was normal. The problems in diagnosis and treatment are discussed.

Publication types

  • Case Reports

MeSH terms

  • Cholestasis / blood
  • Cholesterol / blood
  • Emulsions
  • Female
  • Graft vs Host Disease / complications
  • Homozygote
  • Humans
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / metabolism*
  • Infusions, Intravenous
  • Lipids / chemistry
  • Lipoprotein-X / blood*
  • Liver Cirrhosis, Biliary / complications
  • Liver Cirrhosis, Biliary / metabolism*
  • Liver Transplantation / adverse effects*
  • Middle Aged
  • Reoperation
  • Treatment Outcome

Substances

  • Emulsions
  • Lipids
  • Lipoprotein-X
  • Cholesterol